Therapeutics: HCV NS5A protein

Infectious disease

INDICATION: Hepatitis C virus (HCV)

In vitro studies suggest combining inhibitors of HCV NS5A protein could help treat Daklinza daclatasvir-resistant HCV infection. Screening of

Read the full 241 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE